Use

Used to identify unexpected red blood cell (RBC) antibodies in a prenatal patient’s serum and/or coating their RBCs. The results help assess risk for hemolytic disease of the fetus and newborn (HDFN) and assist in determining Rh immunoglobulin administration. This test is specifically for prenatal patients and should not be used for non‐prenatal testing.